Programmed ribosomal frameshifting in HIV-1 and the SARS-CoV

Virus Research

Volumn 119, Issue 1, 2006, Pages 29-42

  Brierley, Ian ^a   Dos Ramos, Francisco J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Coronavirus; HIV 1; Retrovirus; Ribosomal frameshifting; RNA pseudoknot; SARS CoV; Translation

Indexed keywords

1,4 BIS [N {3 N,N DIMETHYLPROPYL} AMIDINO]BENZENE TETRAHYDROCHLORIDE; ANISOMYCIN; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CHLORIDE; CYCLOHEXIMIDE; MORPHOLINE DERIVATIVE; PHOSPHORODIAMINODATE MORPHOLINE; RG 501; SPARSOMYCIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CHIMERA; DRUG BINDING; DRUG INHIBITION; DRUG TARGETING; GENE DELETION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; IN VIVO STUDY; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RIBOSOMAL FRAMESHIFTING; RNA STRUCTURE; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRAL GENETICS; VIRION; VIRUS REPLICATION;

BASE SEQUENCE; FRAMESHIFTING, RIBOSOMAL; GENE EXPRESSION REGULATION, VIRAL; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; PROTEIN BIOSYNTHESIS; REGULATORY SEQUENCES, RIBONUCLEIC ACID; RNA, VIRAL; SARS VIRUS;

CORONAVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES; SARS CORONAVIRUS;

EID: 33646779223     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2005.10.008     Document Type: Article

References (145)

1. Atkins J.F., Baranov P.V., Fayet O., Herr A.J., Howard M.T., Ivanov I.P., Matsufuji S., Miller W.A., Moore B., Prere M.F., Wills N.M., Zhou J., and Gesteland R.F. Overriding standard decoding: implications of recoding for ribosome function and enrichment of gene expression. Cold Spring Harb. Symp. Q. Biol. 66 (2001) 217-232
2. Aupeix K., Le Tinevez R., and Toulme J.J. Binding of oligopyrimidines to the RNA hairpin responsible for the ribosome Gag-Pol frameshift in HIV-1. FEBS Lett. 449 (1999) 169-174
3. Aupeix-Scheidler K., Chabas S., Bidou L., Rousset J.P., Leng M., and Toulme J.J. Inhibition of in vitro and ex vivo translation by a transplatin-modified oligo (2′-O-methylribonucleotide) directed against the HIV-1 Gag-Pol frameshift signal. Nucleic Acids Res. 28 (2000) 438-445
4. Baranov P.V., Henderson C.M., Anderson C.B., Gesteland R.F., Atkins J.F., and Howard M.T. Programmed ribosomal frameshifting in decoding the SARS-CoV genome. Virology 332 (2005) 498-510
5. Baric R.S., and Sims A.C. Development of mouse hepatitis virus and SARS-CoV infectious cDNA constructs. Curr. Top. Microbiol. Immunol. 287 (2005) 229-252
6. Baril M., Dulude D., Gendron K., Lemay G., and Brakier-Gingras L. Efficiency of a programmed -1 ribosomal frameshift in the different subtypes of the human immunodeficiency virus type 1 group M. RNA 9 (2003) 1246-1253
7. Baril M., Dulude D., Steinberg S.V., and Brakier-Gingras L. The frameshift stimulatory signal of human immunodeficiency virus type 1 group O is a pseudoknot. J. Mol. Biol. 331 (2003) 571-583
8. Bekaert M., and Rousset J.P. An extended signal involved in eukaryotic-1 frameshifting operates through modification of the E site tRNA. Mol. Cell 17 (2005) 61-68
9. Bertrand C., Prere M.F., Gesteland R.F., Atkins J.F., and Fayet O. Influence of the stacking potential of the base 3′ of tandem shift codons on -1 ribosomal frameshifting used for gene expression. RNA 8 (2002) 16-28
10. Bhardwaj K., Guarino L., and Kao C.C. The severe acute respiratory syndrome coronavirus Nsp15 protein is an endoribonuclease that prefers manganese as a cofactor. J. Virol. 78 (2004) 12218-12224
11. Bidou L., Stahl G., Grima B., Liu H., Cassan M., and Rousset J.P. In vivo HIV-1 frameshifting efficiency is directly related to the stability of the stem-loop stimulatory signal. RNA 3 (1997) 1153-1158
12. Biswas P., Jiang X., Pacchia A.L., Dougherty J.P., and Peltz S.W. The human immunodeficiency virus type 1 ribosomal frameshifting site is an invariant sequence determinant and an important target for antiviral therapy. J. Virol. 78 (2004) 2082-2087
13. Bredenbeek P.J., Pachuk C.J., Noten A.F., Charite J., Luytjes W., Weiss S.R., and Spaan W.J. The primary structure and expression of the second open reading frame of the polymerase gene of the coronavirus MHV-A59: a highly conserved polymerase is expressed by an efficient ribosomal frameshifting mechanism. Nucleic Acids Res. 18 (1990) 1825-1832
14. Brierley I. Ribosomal frameshifting on viral RNAs. J. Gen. Virol. 76 (1995) 1885-1892
15. Brierley I., and Pennell S. Structure and function of the stimulatory RNAs involved in programmed eukaryotic-1 ribosomal frameshifting. Cold Spring Harb. Symp. Q. Biol. 66 (2001) 233-248
16. Brierley I., Boursnell M.E., Binns M.M., Bilimoria B., Blok V.C., Brown T.D., and Inglis S.C. An efficient ribosomal frame-shifting signal in the polymerase-encoding region of the coronavirus IBV. EMBO J. 6 (1987) 3779-3785
17. Brierley I., Digard P., and Inglis S.C. Characterization of an efficient coronavirus ribosomal frameshifting signal: requirement for an RNA pseudoknot. Cell 57 (1989) 537-547
18. Brierley I., Rolley N.J., Jenner A.J., and Inglis S.C. Mutational analysis of the RNA pseudoknot component of a coronavirus ribosomal frameshifting signal. J. Mol. Biol. 220 (1991) 889-902
19. Brierley I., Jenner A.J., and Inglis S.C. Mutational analysis of the 'slippery-sequence' component of a coronavirus ribosomal frameshifting signal. J. Mol. Biol. 227 (1992) 463-479
20. Brunelle M.N., Brakier-Gingras L., and Lemay G. Replacement of murine leukemia virus readthrough mechanism by human immunodeficiency virus frameshift allows synthesis of viral proteins and virus replication. J. Virol. 77 (2003) 3345-3350
21. Cassan M., Delaunay N., Vaquero C., and Rousset J.P. Translational frameshifting at the Gag-Pol junction of human immunodeficiency virus type 1 is not increased in infected T-lymphoid cells. J. Virol. 68 (1994) 1501-1508
22. Cen S., Niu M., Saadatmand J., Guo F., Huang Y., Nabel G.J., and Kleiman L. Incorporation of pol into human immunodeficiency virus type 1 gag virus-like particles occurs independently of the upstream gag domain in Gag-Pol. J. Virol. 78 (2004) 1042-1049
23. Chandler M., and Fayet O. Translational frameshifting in the control of transposition in bacteria. Mol. Microbiol. 7 (1993) 497-503
24. Chen X., Chamorro M., Lee S.I., Shen L.X., Hines J.V., Tinoco Jr. I., and Varmus H.E. Structural and functional studies of retroviral RNA pseudoknots involved in ribosomal frameshifting: nucleotides at the junction of the two stems are important for efficient ribosomal frameshifting. EMBO J. 14 (1995) 842-852
25. Chen X.Y., Kang H.S., Shen L.X., Chamorro M., Varmus H.E., and Tinoco I. A characteristic bent conformation of RNA pseudoknots promotes-1 frameshifting during translation of retroviral RNA. J. Mol. Biol. 260 (1996) 479-483
26. Cheng A., Zhang W., Xie Y., Jiang W., Arnold E., Sarafianos S.G., and Ding J. Expression, purification and characterisation of the SARS coronavirus RNA polymerase. Virology 335 (2005) 165-176
27. Cherry E., Liang C., Rong L., Quan Y., Inouye P., Li X., Morin N., Kotler M., and Wainberg M.A. Characterization of human immunodeficiency virus type-1 (HIV-1) particles that express protease-reverse transcriptase fusion proteins. J. Mol. Biol. 284 (1998) 43-56
28. Chim S.S., Tsui S.K., Chan K.C., Au T.C., Hung E.C., Tong Y.K., Chiu R.W., Ng E.K., Chan P.K., Chu C.M., Sung J.J., Tarn J.S., Fung K.P., Waye M.M., Lee C.Y., Yuen K.Y., Lo Y.M., and CUHK Molecular SARS Research Group. Genomic characterisation of the severe acute respiratory syndrome coronavirus of Amoy Gardens outbreak in Hong Kong. Lancet 362 (2003) 1807-1808
29. Chinese SARS Molecular Epidemiology Consortium. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 303 (2004) 1666-1669
30. Cowley J.A., Dimmock C.M., Spann K.M., and Walker P.J. Gill-associated virus of Penaeus monodon prawns: an invertebrate virus with ORF1a and ORF1b genes related to arteri- and coronaviruses. J. Gen. Virol. 81 (2000) 1473-1484
31. Demirov D.G., and Freed E.O. Retrovirus budding. Virus Res. 106 (2004) 87-102
32. den Boon J.A., Snijder E.J., Chirnside E.D., de Vries A.A., Horzinek M.C., and Spaan W.J. Equine arteritis virus is not a togavirus but belongs to the coronaviruslike superfamily. J. Virol. 65 (1991) 2910-2920
33. Dinman J.D. Ribosomal frameshifting in yeast viruses. Yeast 11 (1995) 1115-1127
34. Dinman J.D., and Wickner R.B. Ribosomal frameshifting efficiency and gag/Gag-Pol ratio are critical for yeast M1 double-stranded RNA virus propagation. J. Virol. 66 (1992) 3669-3676
35. Dinman J.D., Ruiz-Echevarria M.J., Czaplinski K., and Peltz S.W. Peptidyl-transferase inhibitors have antiviral properties by altering programmed-1 ribosomal frameshifting efficiencies: development of model systems. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 6606-6611
36. Dinman J.D., Ruiz-Echevarria M.J., and Peltz S.W. Translating old drugs into new treatments: ribosomal frameshifting as a target for antiviral agents. Trends Biotechnol. 16 (1998) 190-196
37. Dinman J.D., Richter S., Plant E.P., Taylor R.C., Hammell A.B., and Rana T.M. The frameshift signal of HIV-1 involves a potential intramolecular triplex RNA structure. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 5331-5336
38. Dos Ramos F., Carrasco M., Doyle T., and Brierley I. Programmed -1 ribosomal frameshifting in the SARS coronavirus. Biochem. Soc. Trans. 32 (2004) 1081-1083
39. Doyon L., Croteau G., Thibeault D., Poulin F., Pilote L., and Lamarre D. Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors. J. Virol. 70 (1996) 3763-3769
40. Doyon L., Payant C., Brakier-Gingras L., and Lamarre D. Novel Gag-Pol frameshift site in human immunodeficiency virus type 1 variants resistant to protease inhibitors. J. Virol. 72 (1998) 6146-6150
41. Draper D.E. Pseudoknots and the control of protein synthesis. Curr. Opin. Cell. Biol. 2 (1990) 1099-1103
42. Drosten C., Gunther S., Preiser W., van der Werf S., Brodt H.R., Becker S., Rabenau H., Panning M., Kolesnikova L., Fouchier R.A., Berger A., Burguiere A.M., Cinatl J., Eickmann M., Escriou N., Grywna K., Kramme S., Manuguerra J.C., Muller S., Rickerts V., Sturmer M., Vieth S., Klenk H.D., Osterhaus A.D., Schmitz H., and Doerr H.W. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348 (2003) 1967-1976
43. Du Z., Giedroc D.P., and Hoffman D.W. Structure of the autoregulatory pseudoknot within the gene 32 messenger RNA of bacteriophages T2 and T6: a model for a possible family of structurally related RNA pseudoknots. Biochemistry 35 (1996) 4187-4198
44. Dulude D., Baril M., and Brakier-Gingras L. Characterization of the frameshift stimulatory signal controlling a programmed -1 ribosomal frameshift in the human immunodeficiency virus type 1. Nucleic Acids Res. 30 (2002) 5094-5102
45. Egloff M.P., Ferron F., Campanacci V., Longhi S., Rancurel C., Dutartre H., Snijder E.J., Gorbalenya A.E., Cambillau C., and Canard B. The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 3792-3796
46. Eickmann M., Becker S., Klenk H.D., Doerr H.W., Stadler K., Censini S., Guidotti S., Masignani V., Scarselli M., Mora M., Donati C., Han J.H., Song H.C., Abrignani S., Covacci A., and Rappuoli R. Phylogeny of the SARS coronavirus. Science 302 (2003) 1504-1505
47. Eleouet J.F., Rasschaert D., Lambert P., Levy L., Vende P., and Laude H. Complete sequence (20 kilobases) of the polyprotein-encoding gene 1 of transmissible gastroenteritis virus. Virology 206 (1995) 817-822
48. Fan K., Wei P., Feng Q., Chen S., Huang C., Ma L., Lai B., Pei J., Liu Y., Chen J., and Lai L. Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase. J. Biol. Chem. 279 (2004) 1637-1642
49. Farabaugh P.J. Programmed translational frameshifting. Microb. Rev. 60 (1996) 103-134
50. Farabaugh P.J. Translational frameshifting: implications for the mechanism of translational frame maintenance. Prog. Nucleic Acids Res. Mol. Biol. 64 (2000) 131-170
51. Fouchier R.A., Kuiken T., Schutten M., van Amerongen G., van Doornum G.J., van den Hoogen B.G., Peiris M., Lim W., Stohr K., and Osterhaus A.D. Aetiology: Koch's postulates fulfilled for SARS virus. Nature 423 (2003) 240
52. Futterer J., and Hohn T. Translation in plants-rules and exceptions. Plant Mol. Biol. 32 (1996) 159-189
53. Gale Jr. M., Tan S.L., and Katze M.G. Translational control of viral gene expression in eukaryotes. Microbiol. Mol. Biol. Rev. 64 (2000) 239-280
54. Gao F., Ou H.Y., Chen L.L., Zheng W.X., and Zhang C.T. Prediction of proteinase cleavage sites in polyproteins of coronaviruses and its applications in analyzing SARS-CoV genomes. FEBS Lett. 553 (2003) 451-456
55. Gaudin C., Mazauric M.H., Traikia M., Guittet E., Yoshizawa S., and Fourmy D. Structure of the RNA signal essential for translational frameshifting in HIV-1. J. Mol. Biol. 349 (2005) 1024-1035
56. Gendron K., Dulude D., Lemay G., Ferbeyre G., and Brakier-Gingras L. The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1. Virology 334 (2005) 342-352
57. Gibbs A.J., Gibbs M.J., and Armstrong J.S. The phylogeny of SARS coronavirus. Arch. Virol. 149 (2004) 621-624
58. Giedroc D.P., Theimer C.A., and Nixon P.L. Structure, stability and function of RNA pseudoknots involved in stimulating ribosomal frameshifting. J. Mol. Biol. 298 (2000) 167-185
59. Gottlinger H.G., Dorfman T., Sodroski J.G., and Haseltine W.A. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 3195-3199
60. Greatorex J., Gallego J., Varani G., and Lever A. Structure and stability of wild-type and mutant RNA internal loops from the SL-1 domain of the HIV-1 packaging signal. J. Mol. Biol. 322 (2002) 543-557
61. Guan Y., Zheng B.J., He Y.Q., Liu X.L., Zhuang Z.X., Cheung C.L., Luo S.W., Li P.H., Zhang L.J., Guan Y.J., Butt K.M., Wong K.L., Chan K.W., Lim W., Shortridge K.F., Yuen K.Y., Peiris J.S., and Poon L.L. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 302 (2003) 276-278
62. Guan Y., Peiris J.S., Zheng B., Poon L.L., Chan K.H., Zeng F.Y., Chan C.W., Chan M.N., Chen J.D., Chow K.Y., Hon C.C., Hui K.H., Li J., Li V.Y., Wang Y., Leung S.W., Yuen K.Y., and Leung F.C. Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome. Lancet 363 (2004) 99-104
63. Harcourt B.H., Jukneliene D., Kanjanahaluethai A., Bechill J., Severson K.M., Smith C.M., Rota P.A., and Baker S.C. Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity. J. Virol. 78 (2004) 13600-13612
64. Herold J., and Siddell S.G. An 'elaborated' pseudoknot is required for high frequency frameshifting during translation of HCV 229E polymerase mRNA. Nucleic Acids Res. 21 (1993) 5838-5842
65. Herold J., Raabe T., Schelle-Prinz B., and Siddell S.G. Nucleotide sequence of the human coronavirus 229E RNA polymerase locus. Virology 195 (1993) 680-691
66. Hill M.K., Shehu-Xhilaga M., Crowe S.M., and Mak J. Proline residues within spacer peptide p1 are important for human immunodeficiency virus type 1 infectivity, protein processing, and genomic RNA dimer stability. J. Virol. 76 (2002) 11245-11253
67. Howard M.T., Gesteland R.F., and Atkins J.F. Efficient stimulation of site-specific ribosome frameshifting by antisense oligonucleotides. RNA 10 (2004) 1653-1661
68. Hung M., Patel P., Davis S., and Green S.R. Importance of ribosomal frameshifting for human immunodeficiency virus type 1 particle assembly and replication. J. Virol. 72 (1998) 4819-4824
69. Irvine J.H., Horsfield J.A., McKinney C.Z., and Tate W.P. A novel strategy to interfere with human immunodeficiency virus type 1 propagation. N. Z. Med. J. 111 (1998) 222-224
70. Ivanov K.A., Thiel V., Dobbe J.C., van der Meer Y., Snijder E.J., and Ziebuhr J. Multiple enzymatic activities associated with severe acute respiratory syndrome coronavirus helicase. J. Virol. 78 (2004) 5619-5632
71. Ivanov K.A., Hertzig T., Rozanov M., Bayer S., Thiel V., Gorbalenya A.E., and Ziebuhr J. Major genetic marker of nidoviruses encodes a replicative endoribonuclease. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 12694-12699
72. Jacks T., and Varmus H.E. Expression of the Rous sarcoma virus pol gene by ribosomal frameshifting. Science 230 (1985) 1237-1242
73. Jacks T., Madhani H.D., Masiarz F.R., and Varmus H.E. Signals for ribosomal frameshifting in the Rous sarcoma virus Gag-Pol region. Cell 55 (1988) 447-458
74. Jacks T., Power M.D., Masiarz F.R., Luciw P.A., Barr P.J., and Varmus H.E. Characterization of ribosomal frameshifting in HIV-1 Gag-Pol expression. Nature 331 (1988) 280-283
75. Kang H. Direct structural evidence for formation of a stem-loop structure involved in ribosomal frameshifting in human immunodeficiency virus type 1. Biochim. Biophys. Acta 1397 (1998) 73-78
76. Kang H.S., and Tinoco I. A mutant RNA pseudoknot that promotes ribosomal frameshifting in mouse mammary tumor virus. Nucleic Acids Res. 25 (1997) 1943-1949
77. Kang H.S., Hines J.V., and Tinoco I. Conformation of a non-frame shifting RNA pseudoknot from mouse mammary tumor virus. J. Mol. Biol. 259 (1996) 135-147
78. Karacostas V., Wolffe E.J., Nagashima K., Gond M.A., and Moss B. Overexpression of the HIV-1 Gag-Pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles. Virology 193 (1993) 661-671
79. Kaye J.F., and Lever A.M. trans-Acting proteins involved in RNA encapsidation and viral assembly in human immunodeficiency virus type 1. J. Virol. 70 (1996) 880-886
80. Kim Y.G., Maas S., and Rich A. Comparative mutational analysis of cis-acting RNA signals for translational frameshifting in HIV-1 and HTLV-2. Nucleic Acids Res. 29 (2001) 1125-1131
81. Kollmus H., Honigman A., Panet A., and Hauser H. The sequences of and distance between two cis-acting signals determine the efficiency of ribosomal frameshifting in human immunodeficiency virus type 1 and human T-cell leukemia virus type II in vivo. J. Virol. 68 (1994) 6087-6091
82. Kontos H., Napthine S., and Brierley I. Ribosomal pausing at a frameshifter RNA pseudoknot is sensitive to reading phase but shows little correlation with frameshift efficiency. Mol. Cell. Biol. 21 (2001) 8657-8670
83. Ksiazek T.G., Erdman D., Goldsmith C.S., Zaki S.R., Peret T., Emery S., Tong S., Urbani C., Comer J.A., Lim W., Rollin P.E., Dowell S.F., Ling A.E., Humphrey C.D., Shieh W.J., Guarner J., Paddock C.D., Rota P., Fields B., DeRisi J., Yang J.Y., Cox N., Hughes J.M., LeDuc J.W., Bellini W.J., Anderson L.J., and SARS Working Group. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348 (2003) 1953-1966
84. Kuiken T., Fouchier R.A., Schutten M., Rimmelzwaan G.F., van Amerongen G., van Riel D., Laman J.D., de Jong T., van Doornum G., Lim W., Ling A.E., Chan P.K., Tarn J.S., Zambon M.C., Gopal R., Drosten C., van der Werf S., Escriou N., Manuguerra J.C., Stohr K., Peiris J.S., and Osterhaus A.D. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362 (2003) 263-270
85. Lawrence D.C., Stover C.C., Noznitsky J., Wu Z., and Summers M.F. Structure of the intact stem and bulge of HIV-1 Psi-RNA stem-loop SL1. J. Mol. Biol. 326 (2003) 529-542
86. Le S.Y., Shapiro B.A., Chen J.H., Nussinov R., and Maizel J.V. RNA pseudoknots downstream of the frameshift sites of retroviruses. Genet. Anal. Tech. Appl. 8 (1991) 191-205
87. Le S.Y., Chen J.H., Pattabiraman N., and Maizel J.V. Ion-RNA interactions in the RNA pseudoknot of a ribosomal frameshifting site: molecular modeling studies. J. Biomol. Struct. Dyn. 16 (1998) 1-11
88. Lin C.W., Tsai C.H., Tsai F.J., Chen P.L., Lai C.C., Wan L., Chiu H.H., and Lin K.H. Characterization of trans- and cis-cleavage activity of the SARS coronavirus 3CLpro protease: basis for the in vitro screening of anti-SARS drugs. FEBS Lett. 574 (2004) 131-137
89. Liphardt J., Napthine S., Kontos H., and Brierley I. Evidence for an RNA pseudoknot loop-helix interaction essential for efficient-1 ribosomal frameshifting. J. Mol. Biol. 288 (1999) 321-335
90. Lopinski J.D., Dinman J.D., and Bruenn J.A. Kinetics of ribosomal pausing during programmed-1 translational frameshifting. Mol. Cell. Biol. 20 (2000) 1095-1103
91. Louis J.M., Clore G.M., and Gronenborn A.M. Autoprocessing of HIV-1 protease is tightly coupled to protein folding. Nat. Struct. Biol. 6 (1999) 868-875
92. Louis J.M., Wondrak E.M., Kimmel A.R., Wingfield P.T., and Nashed N.T. Proteolytic processing of HIV-1 protease precursor, kinetics and mechanism. J. Biol. Chem. 274 (1999) 23437-23442
93. Lux A., Beil C., Majety M., Barron S., Gallione C.J., Kuhn H.-M., Berg J.N., Kioschis P., Marchuk D.A., and Hafner M. Human retroviral gag- and gag-pol-like proteins interact with the transforming growth factor-β receptor activin receptor-like kinase 1. J. Biol. Chem. 280 (2005) 8482-8493
94. Manktelow E., Shigemoto K., and Brierley I. Characterization of the frameshift signal of Edr, a mammalian example of programmed -1 ribosomal frameshifting. Nucleic Acids Res. 33 (2005) 1553-1563
95. Marra M.A., Jones S.J., Astell C.R., Holt R.A., Brooks-Wilson A., Butterfield Y.S., Khattra J., Asano J.K., Barber S.A., Chan S.Y., Cloutier A., Coughlin S.M., Freeman D., Girn N., Griffith O.L., Leach S.R., Mayo M., McDonald H., Montgomery S.B., Pandoh P.K., Petrescu A.S., Robertson A.G., Schein J.E., Siddiqui A., Smailus D.E., Stott J.M., Yang G.S., Plummer F., Andonov A., Artsob H., Bastien N., Bernard K., Booth T.F., Bowness D., Czub M., Drebot M., Fernando L., Flick R., Garbutt M., Gray M., Grolla A., Jones S., Feldmann H., Meyers A., Kabani A., Li Y., Normand S., Stroher U., Tipples G.A., Tyler S., Vogrig R., Ward D., Watson B., Brunham R.C., Krajden M., Petric M., Skowronski D.M., Upton C., and Roper R.L. The genome sequence of the SARS-associated coronavirus. Science 300 (2003) 1399-1404
96. Martina B.E., Haagmans B.L., Kuiken T., Fouchier R.A., Rimmelzwaan G.F., Van Amerongen G., Peiris J.S., Lim W., and Osterhaus A.D. Virology: SARS virus infection of cats and ferrets. Nature 425 (2003) 915
97. Michiels P.J., Versleijen A.A., Verlaan P.W., Pleij C.W., Hilbers C.W., and Heus H.A. Solution structure of the pseudoknot of SRV-1 RNA, involved in ribosomal frameshifting. J. Mol. Biol. 310 (2001) 1109-1123
98. Morita E., and Sundquist W.I. Retrovirus budding. Annu. Rev. Cell Dev. Biol. 20 (2004) 395-425
99. Napthine S., Liphardt J., Bloys A., Routledge S., and Brierley I. The role of RNA pseudoknot stem 1 length in the promotion of efficient-1 ribosomal frameshifting. J. Mol. Biol. 288 (1999) 305-320
100. Neuman B.W., Stein D.A., Kroeker A.D., Churchill M.J., Kim A.M., Kuhn P., Dawson P., Moulton H.M., Bestwick R.K., Iversen P.L., and Buchmeier M.J. Inhibition, escape and attenuated growth of severe acute respiratory syndrome coronavirus treated with antisense morpholino oligomers. J. Virol. 79 (2005) 9665-9676
101. Noller H.F., Yusupov M.M., Yusupova G.Z., Baucom A., and Cate J.H. Translocation of tRNA during protein synthesis. FEBS Lett. 514 (2002) 11-16
102. Olsthoorn R.C., Laurs M., Sohet F., Hilbers C.W., Heus H.A., and Pleij C.W. Novel application of sRNA: stimulation of ribosomal frameshifting. RNA 10 (2004) 1702-1703
103. Park J., and Morrow C.D. Overexpression of the Gag-Pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production. J. Virol. 65 (1991) 5111-5117
104. Parkin N.T., Chamorro M., and Varmus H.E. Human immunodeficiency virus type 1 Gag-Pol frameshifting is dependent on downstream mRNA secondary structure: demonstration by expression in vivo. J. Virol. 66 (1992) 5147-5151
105. Paulus C., Hellebrand S., Tessmer U., Wolf H., Krausslich H.G., and Wagner R. Competitive inhibition of human immunodeficiency virus type-1 protease by the Gag-Pol transframe protein. J. Biol. Chem. 274 (1999) 21539-21543
106. Pe'ery T., and Mathews M.B. Viral translational strategies and host defense mechanisms. In: Sonenberg N., Hershey J.W.B., and Mathews M.B. (Eds). Translational Control of Gene Expression (2000), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York 371-424
107. Peiris I.S., Lai S.T., Poon L.L., Guan Y., Yam L.Y., Lim W., Nicholls J., Yee W.K., Yan W.W., Cheung M.T., Cheng V.C., Chan K.H., Tsang D.N., Yung R.W., Ng T.K., Yuen K.Y., and SARS Study Group. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361 (2003) 1319-1325
108. Peters S., Munoz M., Yerly S., Sanchez-Merino V., Lopez-Galindez C., Perrin L., Larder B., Cmarko D., Fakan S., Meylan P., and Telenti A. Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein. J. Virol. 75 (2001) 9644-9653
109. Plant E.P., Jacobs K.L., Harger J.W., Meskauskas A., Jacobs J.L., Baxter J.L., Petrov A.N., and Dinman J.D. The 9-A solution: how mRNA pseudoknots promote efficient programmed-1 ribosomal frameshifting. RNA 9 (2003) 168-174
110. Plant E.P., Perez-Alvarado G.C., Jacobs J.L., Mukhopadhyay B., Hennig M., and Dinman J.D. A three-stemmed mRNA pseudoknot in the SARS coronavirus frameshift signal. PLoS Biol. 3 (2005) e172
111. Poon L.L., Guan Y., Nicholls J.M., Yuen K.Y., and Peiris J.S. The aetiology, origins, and diagnosis of severe acute respiratory syndrome. Lancet Infect. Dis. 4 (2004) 663-671
112. Poutanen S.M., Low D.E., Henry B., Finkelstein S., Rose D., Green K., Tellier R., Draker R., Adachi D., Ayers M., Chan A.K., Skowronski D.M., Salit I., Simor A.E., Slutsky A.S., Doyle P.W., Krajden M., Petric M., Brunham R.C., McGeer A.J., National Microbiology Laboratory Canada, and Canadian Severe Acute Respiratory Syndrome Study Team. Identification of severe acute respiratory syndrome in Canada. N. Engl. J. Med. 348 (2003) 1995-2005
113. Prentice E., McAuliffe J., Lu X., Subbarao K., and Denison M.R. Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins. J. Virol. 78 (2004) 9977-9986
114. Reil H., Hoxter M., Moosmayer D., Pauli G., and Hauser H. CD4 expressing human 293 cells as a tool for studies in HIV-1 replication: the efficiency of translational frameshifting is not altered by HIV-1 infection. Virology 205 (1994) 371-375
115. Shehu-Xhilaga M., Crowe S.M., and Mak J. Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity. J. Virol. 75 (2001) 1834-1841
116. Shen L.X., and Tinoco I. The structure of an RNA pseudoknot that causes efficient frameshifting in mouse mammary tumor virus. J. Mol. Biol. 247 (1995) 963-978
117. Shigemoto K., Brennan J., Walls E., Watson C.J., Stott D., Rigby P.W., and Reith A.D. Identification and characterisation of a developmentally regulated mammalian gene that utilises-1 programmed ribosomal frameshifting. Nucleic Acids Res. 29 (2001) 4079-4088
118. Snijder E.J., den Boon J.A., Bredenbeek P.J., Horzinek M.C., Rijnbrand R., and Spaan W.J. The carboxyl-terminal part of the putative Berne virus polymerase is expressed by ribosomal frameshifting and contains sequence motifs which indicate that toro- and coronaviruses are evolutionarily related. Nucleic Acids Res. 18 (1990) 4535-4542
119. Snijder E.J., Bredenbeek P.J., Dobbe J.C., Thiel V., Ziebuhr J., Poon L.L., Guan Y., Rozanov M., Spaan W.J., and Gorbalenya A.E. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J. Mol. Biol. 331 (2003) 991-1004
120. Somogyi P., Jenner A.J., Brierley I., and Inglis S.C. Ribosomal pausing during translation of an RNA pseudoknot. Mol. Cell. Biol. 13 (1993) 6931-6940
121. Song H.D., Tu C.C., Zhang G.W., Wang S.Y., Zheng K., Lei L.C., Chen Q.X., Gao Y.W., Zhou H.Q., Xiang H., Zheng H.J., Chern S.W., Cheng F., Pan C.M., Xuan H., Chen S.J., Luo H.M., Zhou D.H., Liu Y.F., He J.F., Qin P.Z., Li L.H., Ren Y.Q., Liang W.J., Yu Y.D., Anderson L., Wang M., Xu R.H., Wu X.W., Zheng H.Y., Chen J.D., Liang G., Gao Y., Liao M., Fang L., Jiang L.Y., Li H., Chen F., Di B., He L.J., Lin J.Y., Tong S., Kong X., Du L., Hao P., Tang H., Bernini A., Yu X.J., Spiga O., Guo Z.M., Pan H.Y., He W.Z., Manuguerra J.C., Fontanet A., Danchin A., Niccolai N., Li Y.X., Wu C.I., and Zhao G.P. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 2430-2435
122. Stahl G., Bidou L., Rousset J.P., and Cassan M. Versatile vectors to study recoding: conservation of rules between yeast and mammalian cells. Nucleic Acids Res. 23 (1995) 1557-1560
123. Staple D.W., and Butcher S.E. Solution structure of the HIV-1 frameshift inducing stem-loop RNA. Nucleic Acids Res. 31 (2003) 4326-4331
124. Staple D.W., and Butcher S.E. Solution structure and thermodynamic investigation of the HIV-1 frameshift inducing element. J. Mol. Biol. 349 (2005) 1011-1023
125. St-Jean J.R., Jacomy H., Desforges M., Vabret A., Freymuth F., and Talbot P.J. Human respiratory coronavirus OC43: genetic stability and neuroinvasion. J. Virol. 78 (2004) 8824-8834
126. Su L., Chen L., Egli M., Berger J.M., and Rich A. Minor groove RNA triplex in the crystal structure of a ribosomal frameshifting viral pseudoknot. Nat. Struct. Biol. 6 (1999) 285-292
127. Sutton G., Fry E., Carter L., Sainsbury S., Walter T., Nettleship J., Berrow N., Owens R., Gilbert R., Davidson A., Siddell S., Poon L.L., Diprose J., Alderton D., Walsh M., Grimes J.M., and Stuart D.I. The nsp9 replicase protein of SARS-coronavirus, structure and functional insights. Structure (Camb.) 12 (2004) 341-353
128. Takyar S., Hickerson R.P., and Noller H.F. mRNA helicase activity of the ribosome. Cell 120 (2005) 49-58
129. Tanner J.A., Watt R.M., Chai Y.B., Lu L.Y., Lin M.C., Peiris J.S., Poon L.L., Kung H.F., and Huang J.D. The severe acute respiratory syndrome (SARS) coronavirus NTPase/helicase belongs to a distinct class of 5′ to 3′ viral helicases. J. Biol. Chem. 278 (2003) 39578-39582
130. Telenti A., Martinez R., Munoz M., Bleiber G., Greub G., Sanglard D., and Peters S. Analysis of natural variants of the human immunodeficiency virus type 1 Gag-Pol frameshift stem-loop structure. J. Virol. 76 (2002) 7868-7873
131. ten Dam E.B., Pleij C.W., and Bosch L. RNA pseudoknots: translational frameshifting and readthrough on viral RNAs. Virus Genes 4 (1990) 121-136
132. Thiel V., Ivanov K.A., Putics A., Hertzig T., Schelle B., Bayer S., Weissbrich B., Snijder E.J., Rabenau H., Doerr H.W., Gorbalenya A.E., and Ziebuhr J. Mechanisms and enzymes involved in SARS coronavirus genome expression. J. Gen. Virol. 84 (2003) 2305-2315
133. Toulme J.J., Di Primo C., and Moreau S. Modulation of RNA function by oligonucleotides recognizing RNA structure. Prog. Nucleic Acid Res. Mol. Biol. 69 (2001) 1-46
134. Tu C., Tzeng T.H., and Bruenn J.A. Ribosomal movement impeded at a pseudoknot required for frameshifting. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 8636-8640
135. Vickers T.A., and Ecker D.J. Enhancement of ribosomal frameshifting by oligonucleotides targeted to the HIV Gag-Pol region. Nucleic Acids Res. 20 (1992) 3945-3953
136. Vijgen L., Keyaerts E., Moes E., Thoelen I., Wollants E., Lemey P., Vandamme A.M., and Van Ranst M. Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event. J. Virol. 79 (2005) 1595-1604
137. Vijgen L., Keyaerts E., Lemey P., Moes E., Li S., Vandamme A.M., and Van Ranst M. Circulation of genetically distinct contemporary human coronavirus OC43 strains. Virology 337 (2005) 85-92
138. von Grotthuss M., Wyrwicz L.S., and Rychlewski L. mRNA cap-1 methyltransferase in the SARS genome. Cell 113 (2003) 701-702
139. Wilson W., Braddock M., Adams S.E., Rathjen P.D., Kingsman S.M., and Kingsman A.J. HIV expression strategies: ribosomal frameshifting is directed by a short sequence in both mammalian and yeast systems. Cell 55 (1988) 1159-1169
140. Woo P.C., Lau S.K., Chu C.M., Chan K.H., Tsoi H.W., Huang Y., Wong B.H., Poon R.W., Cai J.J., Luk W.K., Poon L.L., Wong S.S., Guan Y., Peiris J.S., and Yuen K.Y. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J. Virol. 79 (2005) 884-895
141. Wu D., Tu C., Xin C., Xuan H., Meng Q., Liu Y., Yu Y., Guan Y., Jiang Y., Yin X., Crameri G., Wang M., Li C., Liu S., Liao M., Feng L., Xiang H., Sun J., Chen J., Sun Y., Gu S., Liu N., Fu D., Eaton B.T., Wang L.F., and Kong X. Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates. J. Virol. 79 (2005) 2620-2625
142. Xu R.H., He J.F., Evans M.R., Peng G.W., Field H.E., Yu D.W., Lee C.K., Luo H.M., Lin W.S., Lin P., Li L.H., Liang W.J., Lin J.Y., and Schnur A. Epidemiologic clues to SARS origin in China. Emerg. Infect. Dis. 10 (2004) 1030-1037
143. Yelverton E., Lindsley D., Yamauchi P., and Gallant J.A. The function of a ribosomal frameshifting signal from human immunodeficiency virus-1 in Escherichia coli. Mol. Microbiol. 11 (1994) 303-313
144. Yusupova G.Z., Yusupov M.M., Cate J.H., and Noller H.F. The path of messenger RNA through the ribosome. Cell 106 (2001) 233-241
145. Zhong N.S., Zheng B.J., Li Y.M., Poon L.L.M., Xie Z.H., Chan K.H., Li P.H., Tan S.Y., Chang Q., Xie J.P., Liu X.Q., Xu L., Li D.X., Yuen K.Y., Peiris J.S.M., and Guan Y. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet 362 (2003) 1353-1358